BEGIN:VCALENDAR VERSION:2.0 PRODID:-//Harvard Law School//NONSGML Events//EN CALSCALE:GREGORIAN X-WR-CALNAME:Harvard Law School - Events X-ORIGINAL-URL:https://hls.harvard.edu/calendar/ X-WR-CALDESC:Harvard Law School - Events BEGIN:VEVENT UID:20260226T1946Z-1772135191.7402-EO-741990-1@10.73.7.213 STATUS:CONFIRMED DTSTAMP:20260416T021617Z CREATED:20260226T150504Z LAST-MODIFIED:20260319T163733Z DTSTART;TZID=America/New_York:20260323T123000 DTEND;TZID=America/New_York:20260323T131500 SUMMARY: HALB x Gunderson: ECVC Law\, Venture-Backed Growth\, and the Anato my of a Multibillion Dollar Acquisition DESCRIPTION: Join HALB for a fireside chat featuring Tim Ehrlich (Partner\, Gunderson Dettmer) and Stuart Chaffee (formerly Chief Business Officer\, A ffinivax). Together\, they will unpack the legal and strategic path of a ve nture-backed company from growth stage to multibillion-dollar acquisition. Using GSK’s acquisition of Affinivax\, a deal valued at up to $3.3 billion\ , as a case […] X-ALT-DESC;FMTTYPE=text/html:

Join HALB for a fireside chat featuring Ti m Ehrlich (Partner\, Gunderson Dettmer) and Stuart Chaffee (formerly Chief Business Officer\, Affinivax). Together\, they will unpack the legal and st rategic path of a venture-backed company from growth stage to multibillion- dollar acquisition. Using GSK’s acquisition of Affinivax\, a deal valued at up to $3.3 billion\, as a case study\, this conversation will offer a behi nd-the-scenes look at ECVC (Emerging Companies\, Venture Capital) law in pr actice.

LOCATION:WCC\; 1015 Classroom GEO:0;0 ORGANIZER;CN="API User":MAILTO:api@law.harvard.edu URL;VALUE=URI:https://hls.harvard.edu/events/halb-ecvc/ END:VEVENT BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 DTSTART:20260308T070000 TZNAME:EDT END:DAYLIGHT END:VTIMEZONE END:VCALENDAR